THE USE OF CANNABIDIOL AS AN ADJUNCTIVE THERAPY IN THE TREATMENT OF PERIODONTAL DISEASE: A LITERATURE REVIEW
DOI:
https://doi.org/10.51891/rease.v12i11.32251Keywords:
Cannabidiol, Periodontal disease, Inflammation, Periodontal treatment, DentistryAbstract
Periodontal disease is a chronic inflammatory condition that affects the tissues responsible for supporting the teeth and is mainly associated with biofilm accumulation and the host's immunoinflammatory response. In this context, cannabidiol (CBD), one of the components of Cannabis sativa and a non-psychoactive compound, has attracted interest in the healthcare field due to its potential anti-inflammatory and antimicrobial properties. This study aimed to analyze the use of cannabidiol as a possible complementary alternative for the treatment of periodontal disease. An integrative literature review was conducted using a qualitative and descriptive approach, based on the PubMed and SciELO databases, considering studies published between 2020 and 2026 in English and Portuguese. Studies addressing the potential anti-inflammatory, antimicrobial, and therapeutic effects of CBD related to periodontal conditions were analyzed. The findings showed promising effects of cannabidiol in reducing inflammatory markers, bleeding, and other signs associated with gingival inflammation. However, limitations were observed regarding the limited number of clinical studies, differences in study protocols, variations in doses and routes of administration, and the lack of long-term follow-up. Therefore, it is concluded that CBD has potential as a complementary treatment to conventional periodontal therapy. Nevertheless, further clinical studies, particularly larger and more standardized studies, are needed to confirm its efficacy and safety and to establish its applicability in dental practice.
Downloads
Downloads
Published
Issue
Section
Categories
License
Atribuição CC BY